Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iloprost Add-On to Bosentan in PAH
NCT00086463Phase 2Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Jun 2004
- Primary completion
- Jan 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in pulmonary arterial hypertension (PAH) comparing Iloprost + Bosentan with Placebo + Bosentan (2 arms). Primary endpoint: Change in 6-Minute Walk Distance at 12 weeks. Started Jun 2004; status: completed.
02
Drugs
iloprost
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00086463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00086463.